PROCEEDINGS VOLUME 9930
SPIE NANOSCIENCE + ENGINEERING | 28 AUGUST - 1 SEPTEMBER 2016
Biosensing and Nanomedicine IX
Proceedings Volume 9930 is from: Logo
SPIE NANOSCIENCE + ENGINEERING
28 August - 1 September 2016
San Diego, California, United States
Front Matter: Volume 9930
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993001 (10 November 2016); doi: 10.1117/12.2258333
Imaging and Spectroscopy
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993003 (3 November 2016); doi: 10.1117/12.2239540
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993004 (27 September 2016); doi: 10.1117/12.2236695
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993005 (27 September 2016); doi: 10.1117/12.2237231
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993006 (27 September 2016); doi: 10.1117/12.2238407
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993007 (27 September 2016); doi: 10.1117/12.2237166
Drug Delivery and Therapeutics
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993008 (27 September 2016); doi: 10.1117/12.2238406
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300A (3 November 2016); doi: 10.1117/12.2237993
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300B (27 September 2016); doi: 10.1117/12.2237643
Keynote Session: Joint Session with Conferences 9930 and 9944
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300D (3 November 2016); doi: 10.1117/12.2239899
Bio-Plasmonics
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300F (27 September 2016); doi: 10.1117/12.2238803
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300G (27 September 2016); doi: 10.1117/12.2238324
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300H (3 November 2016); doi: 10.1117/12.2238365
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300I (3 November 2016); doi: 10.1117/12.2238954
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300M (3 November 2016); doi: 10.1117/12.2237253
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300N (3 November 2016); doi: 10.1117/12.2246443
Biosensing
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300O (3 November 2016); doi: 10.1117/12.2237287
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300P (27 September 2016); doi: 10.1117/12.2238709
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300Q (3 November 2016); doi: 10.1117/12.2237350
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300S (27 September 2016); doi: 10.1117/12.2239344
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300U (27 September 2016); doi: 10.1117/12.2237958
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300V (27 September 2016); doi: 10.1117/12.2237874
Poster Session
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300Y (27 September 2016); doi: 10.1117/12.2237379
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 99300Z (27 September 2016); doi: 10.1117/12.2237647
Proc. SPIE 9930, Biosensing and Nanomedicine IX, 993010 (27 September 2016); doi: 10.1117/12.2242668
Back to Top